Analysis Of Income And Expense [Abstract]

Luxempart - Filing #5773830

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Dividend income	47,642,000 EUR	—	—	—	—	—	—	36,398,000 EUR	—	—	—	—
Material income and expense [abstract]
Operating expense excluding cost of sales	7,921,000 EUR	—	—	—	—	—	—	5,953,000 EUR	—	—	—	—
Expenses by nature [abstract]
Classes of employee benefits expense [abstract]
Employee benefits expense	13,392,000 EUR	—	—	—	—	—	—	13,984,000 EUR	—	—	—	—
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense	945,000 EUR	—	—	—	—	—	—	2,658,000 EUR	—	—	—	—
Disclosure of attribution of expenses by nature to their function [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	30,477,000 EUR	30,477,000 EUR	- EUR	- EUR	- EUR	- EUR	- EUR	183,523,000 EUR	- EUR	183,523,000 EUR	- EUR	- EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	30,477,000 EUR	—	—	—	—	—	—	183,523,000 EUR	—	—	—	—